Industry First AI Enabled Emergency Medical Vitals Diagnostics Software Opens Offering to Investors

MARUX, INC. is now offering common shares to the general public through the equity (Reg-CF) crowdfunding platform, WeFunder. The campaign is the first time the AI-enabled medical diagnostics company is offering shares to the public at large, in parallel the company is also raising through private sales of common shares to accredited investors. The offering is priced at a discounted rate per share to non-accredited investors.
By: MARUX, Inc.
1 2 3
Industry first AI real-time medical diagnostic app
Industry first AI real-time medical diagnostic app
DETROIT - Oct. 1, 2020 - PRLog -- The application will be the industry first real-time visual diagnostic tool for emergency medical responders and medical professionals. It is enhanced by machine learning (ML) together with artificial intelligence (AI) and augmented reality (AR), to help in all emergency assessments of physical injuries, vitals including Covid; fully secured by multiple U.S. patents and EU international patent applications.

The information from the device provides patient vital signs and assessments of the person's injuries. This is what MARUX™ is capable of doing but the company is developing and patenting its application as software as a service (SaaS). This will allow a variety of devices to be used.

With ambitious growth plans, MARUX™ is looking for shareholders to invest in its early stages of development and conditional beta testing through a scaled approach with first responder municipalities and hospital groups. The company use of initial crowdfunding rounds will be for furthering it's machine learning and artificial intelligence functionalities for various medical emergency use cases which includes facial visual recognition that extends its reach into Covid pandemic vitals.

The advisory board has education from leading universities and research institutions, including M.I.T., University of Michigan, Washington, Harvard, Michigan State and Wayne State. Its primary founders have 4 startups with multiple exits, 4 patents and 20 years in software development. "We have partnered with leading educational research institutions and have on our leadership team a collective 50 plus years of medical, AI, ML, augmented reality (AR), software, EMS, automotive and transportation safety expertise," adds CEO and Founder, Jonathan Lightning Rayos.

With educational research and automotive safety organizations partnerships in place, the company will have validation for autonomous technology and other mobility testing capabilities. These partnerships will help its go to market strategies into the largest emerging markets being transformed with a combined $280B US market size and a cumulative annual growth rate (CAGR) of over 20%.

MARUX, LLC is a software as a service (SaaS), business intelligence company dedicated to advancing the use of Internet of Things (IoT) technology in the remote medical monitoring, medical diagnostics, and emergency medical services channels. The company is focused on developing extended/cross-reality (XR), augmented reality (AR), machine learning (ML), and artificial intelligence (AI), for remote diagnostics through telematics, and remote monitoring software application in medical healthcare. MARUX is leveraging multiple partnerships across automotive, transportation, emergency medical services (EMS), hospitals, healthcare providers, medical insurance, and technology solutions providers, to develop and commercialize its SaaS in North America, as well as into international regions. For more information, please visit the company's website at

Source:MARUX, Inc.
Email:*** Email Verified
Tags:Artificial Intelligence, Machine Learning, Augmented Reality, Remote medical diagnostics, COVID-19, Medical vitals, Emergency medical responders, Blm
Industry:Medical, Software, Technology
Location:Detroit - Michigan - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Page Updated Last on: Oct 05, 2020

Like PRLog?
Click to Share